Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population

European Journal of Cancer Care

Volumn 21, Issue 2, 2012, Pages 274-280

  Zhang, M ^a   Jin, M ^a   Yu, Y ^a   Zhang, S ^a   Wu, Y ^a   Liu, H ^a,a   Chen, B ^a   Li, Q ^b   Ma, X ^b   Chen, K ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Institute for Cancer Prevention of Jiashan County   (China)

Author keywords

Breast cancer; MiRNA; Physiological characteristics; Risk; SNPs

Indexed keywords

MICRORNA;

AGE; AGED; ARTICLE; ASIAN; BREAST TUMOR; CHINA; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MENARCHE; MIDDLE AGED; RISK; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MENARCHE; MICRORNAS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS;

EID: 84857057077     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2011.01308.x     Document Type: Article

References (38)

1. Bozhanov S.S., Angelova S.G., Krasteva M.E., Markov T.L., Christova S.L., Gavrilov I.G. and Georgieva E.I. (2010) Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer. Journal of Cancer Research and Clinical Oncology 136, 1657-1669.
2. Camps C., Buffa F.M., Colella S., Moore J., Sotiriou C., Sheldon H., Harris A.L., Gleadle J.M. and Ragoussis J. (2008) hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clinical Cancer Research 14, 1340-1348.
3. Chen H., Sun L.Y., Chen L.L., Zheng H.Q. and Zhang Q.F. (2011) A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese. Internal Medicine Journal DOI: 10.1111/j.1445-5994.2011.02434.x.
4. Chen P.Y. and Meister G. (2005) microRNA-guided posttranscriptional gene regulation. Biological Chemistry 386, 1205-1218.
5. Coleman M.P., Forman D., Bryant H., Butler J., Rachet B., Maringe C., Nur U., Tracey E., Coory M., Hatcher J., Mcgahan C.E., Turner D., Marrett L., Gjerstorff M.L., Johannesen T.B., Adolfsson J., Lambe M., Lawrence G., Meechan D., Morris E.J., Middleton R., Steward J. and Richards M.A. (2010) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377, 127-138.
6. Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W. and Nikitin A.Y. (2007) MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Research 67, 8433-8438.
7. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C. and Parkin D.M. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127, 2893-2917.
8. Guttilla I.K. and White B.A. (2009) Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. The Journal of Biological Chemistry 284, 23204-23216.
9. Harris C.C. (1996) p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environmental Health Perspectives 104 (Suppl. 3), 435-439.
10. Hoffman A.E., Zheng T., Yi C., Leaderer D., Weidhaas J., Slack F., Zhang Y., Paranjape T. and Zhu Y. (2009) microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Research 69, 5970-5977.
11. Hu Z., Chen J., Tian T., Zhou X., Gu H., Xu L., Zeng Y., Miao R., Jin G., Ma H., Chen Y. and Shen H. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. The Journal of Clinical Investigation 118, 2600-2608.
12. Hu Z., Liang J., Wang Z., Tian T., Zhou X., Chen J., Miao R., Wang Y., Wang X. and Shen H. (2009) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Human Mutation 30, 79-84.
13. Johnson J., Lagowski J., Sundberg A. and Kulesz-Martin M. (2005) P53 family activities in development and cancer: relationship to melanocyte and keratinocyte carcinogenesis. The Journal of Investigative Dermatology 125, 857-864.
14. Kano M., Seki N., Kikkawa N., Fujimura L., Hoshino I., Akutsu Y., Chiyomaru T., Enokida H., Nakagawa M. and Matsubara H. (2010) miR-145, miR-133a and miR-133b: tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. International Journal of Cancer 127, 2804-2814.
15. Leung A.W., Mak J., Cheung P.S. and Epstein R.J. (2008) Evidence for a programming effect of early menarche on the rise of breast cancer incidence in Hong Kong. Cancer Detection and Prevention 32, 156-161.
16. Li X., Mertens-Talcott S.U., Zhang S., Kim K., Ball J. and Safe S. (2010) MicroRNA-27a indirectly regulates estrogen receptor α expression and hormone responsiveness in MCF-7 breast cancer cells. Endocrinology 151, 2462-2473.
17. Li X.D., Li Z.G., Song X.X. and Liu C.F. (2011) A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 42, 669-673.
18. Lin H., Dai T., Xiong H., Zhao X., Chen X., Yu C., Li J., Wang X. and Song L. (2010) Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS ONE 5, e15797.
19. Liu B., Zhang Y., Jin M., Ni Q., Liang X., Ma X., Yao K., Li Q. and Chen K. (2010) Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Molecular Carcinogenesis 49, 75-84.
20. Liu H., Brannon A.R., Reddy A.R., Alexe G., Seiler M.W., Arreola A., Oza J.H., Yao M., Juan D., Liou L.S., Ganesan S., Levine A.J., Rathmell W.K. and Bhanot G.V. (2010) Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell renal cell carcinoma. BMC Systems Biology 4, 51.
21. Liu Z., Li G., Wei S., Niu J., El-Naggar A.K., Sturgis E.M. and Wei Q. (2010) Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116, 4753-4760.
22. Long N., Moore M.A., Chen W., Gao C.M., Lai M.S., Mizoue T., Oyunchimeg D., Park S., Shin H.R., Tajima K., Yoo K.Y. and Sobue T. (2010) Cancer epidemiology and control in north-East Asia - past, present and future. Asian Pacific Journal of Cancer Prevention 11 (Suppl. 2), 107-148.
23. Ma Y., Yu S., Zhao W., Lu Z. and Chen J. (2010) miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Letters 298, 150-158.
24. Mertens-Talcott S.U., Chintharlapalli S., Li X. and Safe S. (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Research 67, 11001-11011.
25. Pastrello C., Polesel J., Della Puppa L., Viel A. and Maestro R. (2010) Association between hsa-miR-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 31, 2124-2126.
26. Peng S., Kuang Z., Sheng C., Zhang Y., Xu H. and Cheng Q. (2010) Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Digestive Diseases and Sciences 55, 2288-2293.
27. Reinholz M.M., Bruzek A.K., Visscher D.W., Lingle W.L., Schroeder M.J., Perez E.A. and Jenkins R.B. (2009) Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response. The Lancet Oncology 10, 267-277.
28. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., Diehn M., Liu H., Panula S.P., Chiao E., Dirbas F.M., Somlo G., Pera R.A., Lao K. and Clarke M.F. (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603.
29. Sun Q., Gu H., Zeng Y., Xia Y., Wang Y., Jing Y., Yang L. and Wang B. (2010) Hsa-miR-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Science 101, 2241-2247.
30. Tian T., Shu Y., Chen J., Hu Z., Xu L., Jin G., Liang J., Liu P., Zhou X., Miao R., Ma H., Chen Y. and Shen H. (2009) A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiology, Biomarkers and Prevention 18, 1183-1187.
31. Wang C., Bian Z., Wei D. and Zhang J.G. (2011) miR-29b regulates migration of human breast cancer cells. Molecular and Cellular Biochemistry 352, 197-207.
32. Wang R., Wang Z.X., Yang J.S., Pan X., De W. and Chen L.B. (2011) MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 30, 2644-2658.
33. Wu Z.S., Wu Q., Wang C.Q., Wang X.N., Wang Y., Zhao J.J., Mao S.S., Zhang G.H., Zhang N. and Xu X.C. (2010) MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer 10, 542.
34. Xiao J., Lin H., Luo X., Luo X. and Wang Z. (2011) miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress. The EMBO Journal 30, 524-532.
35. Xu B., Feng N.H., Li P.C., Tao J., Wu D., Zhang Z.D., Tong N., Wang J.F., Song N.H., Zhang W., Hua L.X. and Wu H.F. (2010) A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. The Prostate 70, 467-472.
36. Xu Y., Fang F., Zhang J., Josson S., St Clair W.H. and St Clair D.K. (2010) miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes. PLoS ONE 5, e14356.
37. Yan L.X., Huang X.F., Shao Q., Huang M.Y., Deng L., Wu Q.L., Zeng Y.X. and Shao J.Y. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA (New York, N.Y.) 14, 2348-2360.
38. Zhao H., Shen J., Medico L., Wang D., Ambrosone C.B. and Liu S. (2010) A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS ONE 5, e13735.